AXIS CAPITAL HOLDINGS LIMITED (AXS) capitalization

Current snapshot

Market Cap
$7.48B
73.7M shares × $101.41 · as of last filing 2026-03-31
Net Worth
$6.38B
Stockholders' equity · 2026-03-31
Enterprise Value
$8.04B
Market cap + debt − cash
Net Debt
$564.9M
Debt $1.43B − Cash $862.4M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $8.49B
FY'24 2024-12-31 $7.55B
FY'23 2023-12-31 $4.76B
FY'22 2022-12-31 $4.64B
FY'21 2021-12-31 $4.65B
FY'20 2020-12-31 $4.25B
FY'19 2019-12-31 $5.02B
FY'18 2018-12-31 $4.34B
FY'17 2017-12-31 $4.23B
FY'16 2016-12-31 $5.98B
FY'15 2015-12-31 $5.60B
FY'14 2014-12-31 $5.40B
FY'13 2013-12-31 $5.49B
FY'12 2012-12-31 $4.28B
FY'11 2011-12-31 $4.09B
FY'10 2010-12-31 $4.89B
FY'10 2009-12-31 $4.27B
FY'10 2008-12-31 $4.52B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $7.62B
Q4'25 2025-12-31 $7.94B
Q3'25 2025-09-30 $7.53B
Q2'25 2025-06-30 $8.24B
Q1'25 2025-03-31 $8.26B
Q4'24 2024-12-31 $7.35B
Q3'24 2024-09-30 $6.77B
Q2'24 2024-06-30 $6.03B
Q1'24 2024-03-31 $5.57B
Q4'23 2023-12-31 $4.72B
Q3'23 2023-09-30 $4.85B
Q2'23 2023-06-30 $4.62B
Q1'23 2023-03-31 $4.68B
Q4'22 2022-12-31 $4.59B
Q3'22 2022-09-30 $4.16B
Q2'22 2022-06-30 $4.90B
Q1'22 2022-03-31 $5.19B
Q4'21 2021-12-31 $4.62B
Q3'21 2021-09-30 $3.93B
Q2'21 2021-06-30 $4.18B
Q1'21 2021-03-31 $4.21B
Q4'20 2020-12-31 $4.25B
Q3'20 2020-09-30 $3.71B
Q2'20 2020-06-30 $3.43B
Q1'20 2020-03-31 $3.25B
Q4'19 2019-12-31 $4.99B
Q3'19 2019-09-30 $5.64B
Q2'19 2019-06-30 $5.03B
Q1'19 2019-03-31 $4.62B
Q4'18 2018-12-31 $4.32B
Q3'18 2018-09-30 $4.85B
Q2'18 2018-06-30 $4.67B
Q1'18 2018-03-31 $4.82B
Q4'17 2017-12-31 $4.18B
Q3'17 2017-09-30 $4.77B
Q2'17 2017-06-30 $5.46B
Q1'17 2017-03-31 $5.82B
Q4'16 2016-12-31 $5.64B
Q3'16 2016-09-30 $4.91B
Q2'16 2016-06-30 $5.09B
Q1'16 2016-03-31 $5.26B
Q4'15 2015-12-31 $5.40B
Q3'15 2015-09-30 $5.32B
Q2'15 2015-06-30 $5.40B
Q1'15 2015-03-31 $5.22B
Q4'14 2014-12-31 $5.08B
Q3'14 2014-09-30 $4.93B
Q2'14 2014-06-30 $4.71B
Q1'14 2014-03-31 $5.06B
Q4'13 2013-12-31 $5.21B
Q3'13 2013-09-30 $4.91B
Q2'13 2013-06-30 $5.34B
Q1'13 2013-03-31 $4.94B
Q4'12 2012-12-31 $4.08B
Q3'12 2012-09-30 $4.29B
Q2'12 2012-06-30 $4.07B
Q1'12 2012-03-31 $4.20B
Q4'11 2011-12-31 $4.01B
Q3'11 2011-09-30 $3.32B
Q2'11 2011-06-30 $3.97B
Q1'11 2011-03-31 $3.96B
Q4'10 2010-12-31 $4.03B
Q3'10 2010-09-30 $4.43B
Q2'10 2010-06-30 $4.03B
Q1'11 2010-03-31 $4.44B
Q4'10 2009-12-31 $3.75B
Q3'10 2009-09-30 $4.16B
Q2'10 2009-06-30 $3.92B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (AXS CIK 0001214816), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

ARW

ARROW ELECTRONICS, INC.

HALO

HALOZYME THERAPEUTICS, INC.

RARE

ULTRAGENYX PHARMACEUTICAL INC.